The Importance of γ-Glutamyltransferase (GGT) Activity: A Potential Marker of Left Ventricular (LV) Diastolic Function in Diabetic Patients with Cardiovascular Disease

By Zhang Xue-Lian   Wei Li-Qiang   Fu Han-Jing   Pan Su-Fang   Xie Rong-Rong   Yang Jin-Gang  

Endocrine Research, Vol. 35, Iss. 4, 2010-11 ,pp. : 155-164

Informa Healthcare

Access to resources Recommend Favorite

Role of Hyperglycaemia in Pathogenesis of Diabetic Cardiovascular Disease

By  

Vascular Disease Prevention, Vol. 4, Iss. 2, 2007-05 ,pp. : 125-139

Bentham Science Publishers

Access to resources Recommend Favorite

Targets for immunomodulation in cardiovascular disease – where are we now?

By Wainwright Cherry L  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 177-189

Future Medicine

Access to resources Recommend Favorite

HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-01 ,pp. : 190-211

Bentham Science Publishers

Access to resources Recommend Favorite